Critical appraisal of the role of pegloticase in the management of gout
Hang-Korng Ea,1,2 Pascal Richette1,21Hôpital Lariboisière, Rheumatology Department, Paris, France; 2University of Paris Diderot, Sorbonne Paris Cité, Paris, FranceAbstract: Gout is a debilitating disease secondary to chronic hyperuricemia, and the subseque...
Guardado en:
Autores principales: | Ea HK, Richette P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8e18795e73864186be5d03b70f4f19f6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of pegloticase on patient outcomes in refractory gout: current perspectives
por: Cunha RN, et al.
Publicado: (2018) -
The epidemiology and treatment of gout
por: McGill NW
Publicado: (2011) -
Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
por: Augustine JM, et al.
Publicado: (2012) -
Contentious Issues in Gout Management: The Story so Far
por: Talaat M, et al.
Publicado: (2021) -
The role of extended scope physiotherapists in managing patients with inflammatory arthropathies: a systematic review
por: Stanhope J, et al.
Publicado: (2012)